Senior Director, Rare Endocrinology and Rare Tumors Patient Services

AstraZeneca•Boston, MA

1d•Onsite

About The Position

The Senior Director, Rare Endocrinology and Rare Tumors (RERT), Patient Services (PS) is responsible for leading the Patient Services function for the RERT Business Unit. This includes driving the development and implementation of the PS strategy for four indications: Hypophosphatasia (HPP), Lysosomal Acid Lipase Deficiency (LAL-D), Neurofibromatosis Type 1 plus Plexiform Neurofibromas (NF1 PN), as well as potential future indications and assets. This critical leadership role will work closely with RERT Business Unit leadership to set the PS strategy, manage business performance, identify and manage relationships with 3rd parties (e.g., specialty pharmacies), and identify opportunities to improve performance to better serve patients. The role is responsible for developing Patient Services strategy and its execution via field-based teams, including the Case Management team, the Patient Education Manager team, and the Field Reimbursement Team. Success requires the ability to influence without authority and collaborate cross-functionally with marketing, market access, commercial operations, compliance, IT, legal, regulatory, training, medical, and field leadership. This leader ensures tight alignment with the business strategy to optimize opportunities to serve and educate patients compliantly.

Requirements

Bachelor’s degree in a scientific or business field
15+ years related experience in the biotechnology industry
Significant commercial experiences, with demonstrated success in patient services leadership positions preferred
Ability to adapt in a rapidly evolving environment and with changing technology; bias toward proactively identifying problems and implement solutions; must have a learning mindset and strong personal accountability
Proven, consistent history of high performance regardless of position or company
Exceptional communication skills and ability to build strong cross-functional partnerships
Understanding of compliance regulations and guidance governing copay and patient assistance programs, and commercial and government payer benefit interpretation
Launch experience and/or experience in high growth areas
High learning agility
Prior experience managing people
High level of interpersonal skills and highly adept in both verbal & written communication

Nice To Haves

MBA preferred
Broad base of experiences in patient services, field leadership, analytics, vendor management, marketing, market research, sales, and/or medical affairs is welcomed
Rare disease/high-value biologics experience

Responsibilities

Leading and continuing to evolve the US PS best-in-class strategy and operating model for the US RERT business unit.
Overseeing the design of the Patient Services model for new launches and continuing to evolve existing indications’ models to ensure the team is using AI and technology to scale and enhance the patient experience.
Managing 3rd party vendor relationships to ensure achievement of KPIs and key business objectives as well as compliance and quality.
Partnering closely with Marketing, Market Access, Patient Advocacy, Legal, Compliance, Quality, Drug Safety, Commercial Operations, IT, Training, third parties and vendors to ensure that patient support programs and messaging are effectively meeting the needs of patients.
Recommending program design innovations and lead implementation plans to senior leadership, with rationale for design selection and financial impact. Work cross-functionally to design the Patient Services model for future launches.
Working closely with other members of Patient Services Leadership Team to drive department wide optimization.
Leading development of US strategic planning (3yr/1 yr.) for RERT PS, including tactical plans and budget allocation.
Working with Market Access, Commercial Operations and IT to ensure effective data flow with distribution partners to effectively manage the business.
Partnering with commercial insights to conduct innovative research/analytics to identify key business dynamics, behavioral barriers, segmentation, and barriers to initiation and adherence.
Establishing process for collection and sharing of best practices.
Conducting work consistent with Astra Zeneca’s values: Put Patients First, Do the Right Thing, Play to Win, Be Entrepreneurial, and Follow the Science.
Making decisions consistent with Alexion, Astra Zeneca Rare Disease’s strong commitment to compliance and integrity, and respect for all laws, regulations, and company policies.